id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3237784,e86e2c46-950b-485d-b41e-eccb79174d92,Q3,"NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)",28264,NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD),2024,third_quarter,PHA,Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2024-10-15T10:45:24-04:00